Gupta, S.; Amaout, A.; Theodossi, A.; Mendall, M. A.
April 2004
Gut;Apr2004 Supplement 3, Vol. 53, pA59
Academic Journal
Barrett's esophagus (BO) is a premalignant condition with histopathological evidence of dysplasia being the best marker of increased cancer risk. Of the 273 patients with histology confirmed BO, there were 45 patients with low grade dysplasia (LGD) and 2 patients with high grade dysplasia identified at some point. Authors undertook a retrospective analysis to determine the clinical outcome of patients with LGD. In the era of proton pump inhibitor therapy, about two third of cases of LGD in patients with underlying BO showed "regression" while none progressed to high grade dysplasia or carcinoma oesophagus.


Related Articles

  • Proton pump inhibitors reduce the incidence of dysplasia in Barrett's esophagus. Aguirre, Thomas; El-Serag, Hashem; Davis, Stephanie; Bhattacharyya, Achyut; Sampliner, Richard // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS23 

    An abstract of the article "Proton Pump Inhibitors Reduce the Incidence of Dysplasia in Barrett's Esophagus," by Thomas Aguirre, Hashem El-Serag, Stephanie Davis, Achyut Bhattacharyya and Richard Sampliner is presented.

  • Maintenance proton pump inhibitor (PPI) therapy decreases the incidence of esophageal cancer (CA) and high grade dysplasia (HGD) in Barrett's and chronic heartburn. Bank, Simmy; Singh, Ranvir; Indaram, Anant; Pooran, Nakechand // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS31 

    An abstract of the article "Maintenance Proton Pump Inhibitor (PPI) Therapy Decreases the Incidence of Esophageal Cancer (CA) and High Grade Dysplasia (HGD) in Barrett's and Chronic Heartburn," by Simmy Bank, Ranvir Singh, Anant Indaram and Nakechand Pooran is presented.

  • The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study. Su Jin Hong; Soo-Heon Park; Jeong Seop Moon; Woon Geon Shin; Jae Gyu Kim; Yong Chan Lee; Dong Ho Lee; Jae Young Jang; Kim, Jae J.; Hang-Lak Lee; Sang Woo Lee; Young Hwangbo; Jianming Xu; Bangmao Wang; Zhanxiong Xue; Fei Liu; Yaozong Yuan; Somchai Leelakusolvong; Dy, Frederick // Gut & Liver;Nov2016, Vol. 10 Issue 6, p910 

    Background/Aims: To investigate the effects of esomeprazole and rebamipide combination therapy on symptomatic improvement in patients with reflux esophagitis. Methods: A total of 501 patients with reflux esophagitis were randomized into one of the following two treatment regimens: 40 mg...

  • Elevated Serum Gastrin Is Associated With a History of Advanced Neoplasia in Barrett's Esophagus. Wang, Judy S; Varro, Andrea; Lightdale, Charles J; Lertkowit, Nantaporn; Slack, Kristen N; Fingerhood, Michael L; Tsai, Wei Yann; Wang, Timothy C; Abrams, Julian A // American Journal of Gastroenterology;May2010, Vol. 105 Issue 5, p1039 

    OBJECTIVES:Proton pump inhibitors (PPIs) are frequently prescribed to patients with Barrett's esophagus (BE), but in a subset, they can induce significant hypergastrinemia. Elevated levels of gastrin have been associated with tumorigenic effects in a number of gastrointestinal cancers. We...

  • Accuracy of multidetector-row CT for restaging after neoadjuvant treatment in patients with oesophageal cancer. Konieczny, Agnieszka; Meyer, Philipp; Schnider, Annelies; Komminoth, Paul; Schmid, Mathias; Lombriser, Norbert; Weishaupt, Dominik // European Radiology;Sep2013, Vol. 23 Issue 9, p2492 

    Objectives: To assess the diagnostic accuracy of 64-multidetector CT (MDCT) for restaging of patients with oesophageal cancer undergoing neoadjuvant therapy. Methods: Results of pathological staging were correlated with those from 64-MDCT before and after neoadjuvant treatment in 35 patients...

  • Review on novel concepts of columnar lined esophagus. Lenglinger, Johannes; See, Stephanie Fischer; Beller, Lukas; Cosentini, Enrico P.; Asari, Reza; Wrba, Fritz; Riegler, Martin; Schoppmann, Sebastian F. // Wiener Klinische Wochenschrift;Oct2013, Vol. 125 Issue 19/20, p577 

    Background: Columnar lined esophagus (CLE) is a marker for gastroesophageal reflux and associates with an increased cancer risk among those with Barrett's esophagus. Recent studies fostered the development of integrated CLE concepts. Methods: Using PubMed, we conducted a review of studies on...

  • Barrett's oesophagus: size does matter. de Jonge, Pieter J. F.; Hvid-Jensen, Frederik // Gut;Feb2016, Vol. 65 Issue 2, p189 

    The article discusses research on the evidence for risk stratification of patients with Barrett's oesophagus (BO) according to BO length. It references a study by H. Pohl et al published within the issue. Topics covered include the estimated annual cancer transition rates in relation to...

  • Feasibility of Imaging Esophageal Cancer with Labeled Somatostatin Analogue. Herlin, Gunnar; Ideström, Lars; Lundell, Lars; Aspelin, Peter; Axelsson, Rimma // International Journal of Molecular Imaging;2011, p1 

    Background. While the surface of a cell normally has some amount of somatostatin receptors, these receptors are overexpressed to a very high degree inmultiple neoplastic diseases. No data exist for esophageal carcinoma. Purpose. To find out whether esophageal carcinoma could be imaged using...

  • DNA Content in Barrett's Esophagus and Esophageal Malignancy. McKinley, Matthew J.; Budman, Daniel R.; Grueneberg, Dorre; Bronzo, Richard L.; Weissman, Gary S.; Kahn, Ellen // American Journal of Gastroenterology;Oct1987, Vol. 82 Issue 10, p1012 

    Barrett's esophagus is a premalignant condition; endoscopic surveillance is often performed to search for early adenocarcinoma of the esophagus. In an attempt to detect early changes of malignancy, we have added the use of flow cytometry to routine endoscopic surveillance procedures. DNA...


Read the Article


Sign out of this library

Other Topics